Tech Company Financing Transactions

Tioga Pharmaceuticals Funding Round

Thomas, McNerny & Partners and Genesys Capital joined a $10 million Series B capital raise for Tioga Pharmaceuticals. The funding round was announced on 4/12/2012.

Transaction Overview

Announced On
4/12/2012
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors

Thomas, McNerny & Partners (Lead Investor) (Jason Brown)

Genesys Capital

Proceeds Purpose
Tioga is currently conducting a Phase 3 trial of its compound, asimadoline, for the treatment of diarrhea-predominant irritable bowel syndrome (D-IBS) under a special protocol assessment with the U.S. Food and Drug Administration (FDA).

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4747 Executive Dr. 700
San Diego, CA 92121
USA
Email Address
Not Recorded
Overview
Tioga Pharmaceuticals is engaged in the development of novel therapies for the treatment of gastrointestinal diseases. Tioga is developing asimadoline, a proprietary small molecule, for treating irritable bowel syndrome (IBS) and post operative ileus.
Profile
Tioga Pharmaceuticals LinkedIn Company Profile
Social Media
Tioga Pharmaceuticals Company Twitter Account
Company News
Tioga Pharmaceuticals News
Facebook
Tioga Pharmaceuticals on Facebook
YouTube
Tioga Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stuart Collinson
  Stuart Collinson LinkedIn Profile  Stuart Collinson Twitter Account  Stuart Collinson News  Stuart Collinson on Facebook
Chief Medical Officer
Dawn McGuire
  Dawn McGuire LinkedIn Profile  Dawn McGuire Twitter Account  Dawn McGuire News  Dawn McGuire on Facebook
Chief Operating Officer
Sophie Visonneau
  Sophie Visonneau LinkedIn Profile  Sophie Visonneau Twitter Account  Sophie Visonneau News  Sophie Visonneau on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/12/2012: TalkTo venture capital transaction
Next: 4/12/2012: appRenaissance venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary